Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1880438 · ANTX

AN2 Therapeutics, Inc.

Filing with the SEC SEC-reporting company Menlo Park, CA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Net loss in 2025Net loss of $35.2M for the year (2024: −$51.3M).
  • Private capital raiseOn Mar 25, 2026 the company filed Form D. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$35.2M−$51.3M
Total assets$62M$92.1M
Total liabilities$8.9M$10.2M
Stockholders’ equity$53.1M$81.8M
Cash and equivalents$19.9M$21.4M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
AN2 Therapeutics, Inc.
CIK
0001880438
Tickers
ANTX
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company; Emerging growth company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
Menlo Park, California
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 9, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 9, 2026 · filing · edition of Nov 9, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 9, 2026 · filing · edition of Nov 9, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 11, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 11, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 11, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 11, 2026 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Mar 25, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Mar 20, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 17, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 17, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jan 29, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 12, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 12, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 12, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 13, 2025 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed May 7, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 25, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 25, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 13, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 13, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Nov 5, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 13, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 13, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 2.05, 5.02, 7.01, 8.01, 9.01 · filed Aug 8, 2024 · filing
  • Restructuring or layoffs
    Form 8-K · items 2.05, 5.02, 7.01, 8.01, 9.01 · filed Aug 8, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 14, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 14, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Mar 29, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 28, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 9, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 9, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Sep 8, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 10, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 10, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 11, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 11, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 29, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 29, 2023 · filing